27 related articles for article (PubMed ID: 18827564)
1. High-frequency irreversible electroporation improves survival and immune cell infiltration in rodents with malignant gliomas.
Campelo SN; Lorenzo MF; Partridge B; Alinezhadbalalami N; Kani Y; Garcia J; Saunier S; Thomas SC; Hinckley J; Verbridge SS; Davalos RV; Rossmeisl JH
Front Oncol; 2023; 13():1171278. PubMed ID: 37213298
[TBL] [Abstract][Full Text] [Related]
2. Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy.
Gomes ER; Franco MS
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057001
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation.
Szatmári T; Hargitai R; Sáfrány G; Lumniczky K
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698689
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect between gefitinib and fractionated irradiation in anaplastic oligodendrogliomas cannot be predicted by the Egfr signaling activity.
Pinel S; Mriouah J; Vandamme M; Chateau A; Plénat F; Guérin E; Taillandier L; Bernier-Chastagner V; Merlin JL; Chastagner P
PLoS One; 2013; 8(7):e68333. PubMed ID: 23874590
[TBL] [Abstract][Full Text] [Related]
5. Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.
Reardon DA; Zalutsky MR; Bigner DD
Expert Rev Anticancer Ther; 2007 May; 7(5):675-87. PubMed ID: 17492931
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of pegylated- and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts.
Chastagner P; Sudour H; Mriouah J; Barberi-Heyob M; Bernier-Chastagner V; Pinel S
Pharm Res; 2015 Jan; 32(1):158-66. PubMed ID: 25048636
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition by bortezomib does not translate into efficacy on two malignant glioma xenografts.
Labussiere M; Pinel S; Delfortrie S; Plenat F; Chastagner P
Oncol Rep; 2008 Nov; 20(5):1283-7. PubMed ID: 18949434
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
[TBL] [Abstract][Full Text] [Related]
9. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
Takahashi H; Adachi K; Yamaguchi F; Teramoto A
Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
[TBL] [Abstract][Full Text] [Related]
10. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
11. Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts.
Labussière M; Aarnink A; Pinel S; Taillandier L; Escanyé JM; Barberi-Heyob M; Bernier-Chastagner V; Plénat F; Chastagner P
Anticancer Drugs; 2008 Nov; 19(10):991-8. PubMed ID: 18827564
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601).
Mamelak AN; Jacoby DB
Expert Opin Drug Deliv; 2007 Mar; 4(2):175-86. PubMed ID: 17335414
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
